Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders

Neurological diseases are responsible for approximately 6.8 million deaths every year. They affect up to 1 billion people worldwide and cause significant disability and reduced quality of life. In most neurological disorders, the diagnosis can be challenging; it frequently requires long-term investigation. Thus, the discovery of better diagnostic methods to help in the accurate and fast diagnosis of neurological disorders is crucial. Circulating nucleic acids (CNAs) are defined as any type of DNA or RNA that is present in body biofluids. They can be found within extracellular vesicles or as cell-free DNA and RNA. Currently, CNAs are being explored as potential biomarkers for diseases because they can be obtained using non-invasive methods and may reflect unique characteristics of the biological processes involved in several diseases. CNAs can be especially useful as biomarkers for conditions that involve organs or structures that are difficult to assess, such as the central nervous system. This review presents a critical assessment of the most current literature about the use of plasma and serum CNAs as biomarkers for several aspects of neurological disorders: defining a diagnosis, establishing a prognosis, and monitoring the disease progression and response to therapy. We explored the biological origin, types, and general mechanisms involved in the generation of CNAs in physiological and pathological processes, with specific attention to neurological disorders. In addition, we present some of the future applications of CNAs as non-invasive biomarkers for these diseases.

Saved in:
Bibliographic Details
Main Authors: Bruno,D.C.F., Donatti,A., Martin,M., Almeida,V.S., Geraldis,J.C., Oliveira,F.S., Dogini,D.B., Lopes-Cendes,I.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020001000301
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2020001000301
record_format ojs
spelling oai:scielo:S0100-879X20200010003012020-08-14Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disordersBruno,D.C.F.Donatti,A.Martin,M.Almeida,V.S.Geraldis,J.C.Oliveira,F.S.Dogini,D.B.Lopes-Cendes,I. Circulating nucleic acids Neurological disorders Cell-free DNA Cell-free RNA Biomarker CNAs Neurological diseases are responsible for approximately 6.8 million deaths every year. They affect up to 1 billion people worldwide and cause significant disability and reduced quality of life. In most neurological disorders, the diagnosis can be challenging; it frequently requires long-term investigation. Thus, the discovery of better diagnostic methods to help in the accurate and fast diagnosis of neurological disorders is crucial. Circulating nucleic acids (CNAs) are defined as any type of DNA or RNA that is present in body biofluids. They can be found within extracellular vesicles or as cell-free DNA and RNA. Currently, CNAs are being explored as potential biomarkers for diseases because they can be obtained using non-invasive methods and may reflect unique characteristics of the biological processes involved in several diseases. CNAs can be especially useful as biomarkers for conditions that involve organs or structures that are difficult to assess, such as the central nervous system. This review presents a critical assessment of the most current literature about the use of plasma and serum CNAs as biomarkers for several aspects of neurological disorders: defining a diagnosis, establishing a prognosis, and monitoring the disease progression and response to therapy. We explored the biological origin, types, and general mechanisms involved in the generation of CNAs in physiological and pathological processes, with specific attention to neurological disorders. In addition, we present some of the future applications of CNAs as non-invasive biomarkers for these diseases.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.53 n.10 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020001000301en10.1590/1414-431x20209881
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Bruno,D.C.F.
Donatti,A.
Martin,M.
Almeida,V.S.
Geraldis,J.C.
Oliveira,F.S.
Dogini,D.B.
Lopes-Cendes,I.
spellingShingle Bruno,D.C.F.
Donatti,A.
Martin,M.
Almeida,V.S.
Geraldis,J.C.
Oliveira,F.S.
Dogini,D.B.
Lopes-Cendes,I.
Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
author_facet Bruno,D.C.F.
Donatti,A.
Martin,M.
Almeida,V.S.
Geraldis,J.C.
Oliveira,F.S.
Dogini,D.B.
Lopes-Cendes,I.
author_sort Bruno,D.C.F.
title Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
title_short Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
title_full Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
title_fullStr Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
title_full_unstemmed Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
title_sort circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders
description Neurological diseases are responsible for approximately 6.8 million deaths every year. They affect up to 1 billion people worldwide and cause significant disability and reduced quality of life. In most neurological disorders, the diagnosis can be challenging; it frequently requires long-term investigation. Thus, the discovery of better diagnostic methods to help in the accurate and fast diagnosis of neurological disorders is crucial. Circulating nucleic acids (CNAs) are defined as any type of DNA or RNA that is present in body biofluids. They can be found within extracellular vesicles or as cell-free DNA and RNA. Currently, CNAs are being explored as potential biomarkers for diseases because they can be obtained using non-invasive methods and may reflect unique characteristics of the biological processes involved in several diseases. CNAs can be especially useful as biomarkers for conditions that involve organs or structures that are difficult to assess, such as the central nervous system. This review presents a critical assessment of the most current literature about the use of plasma and serum CNAs as biomarkers for several aspects of neurological disorders: defining a diagnosis, establishing a prognosis, and monitoring the disease progression and response to therapy. We explored the biological origin, types, and general mechanisms involved in the generation of CNAs in physiological and pathological processes, with specific attention to neurological disorders. In addition, we present some of the future applications of CNAs as non-invasive biomarkers for these diseases.
publisher Associação Brasileira de Divulgação Científica
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020001000301
work_keys_str_mv AT brunodcf circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT donattia circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT martinm circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT almeidavs circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT geraldisjc circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT oliveirafs circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT doginidb circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
AT lopescendesi circulatingnucleicacidsintheplasmaandserumaspotentialbiomarkersinneurologicaldisorders
_version_ 1756391613883482112